Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Path_AI
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Path_AI
-
PathAI proslijedio/la je Tweet
Very fun turn out
@Path_AI for@iRobot’s Teresa Borcuch and her talk about using coding challenges to hire data scientists. Look at how much fun everyone is having!pic.twitter.com/sxGYVC7RMf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today we welcomed 20
@MIT students to our office to talk more about PathAI, what it's like working at a start-up, and meet some of members of our team!pic.twitter.com/YvC9afkrTW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PathAI proslijedio/la je Tweet
This week at the
@broadinstitute, the MLSC convened various stakeholders to discuss how#data is rapidly changing patient care. Thank you to our panelists and to attendees for being part of the gathering.#DataScience#LifeSciences#BeyondBits2Bytes
http://ow.ly/Dsjz50xVhOy pic.twitter.com/1AjeU1QiFG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PathAI proslijedio/la je Tweet
How 8 Massachusetts Companies Shaped 4 Most Disruptive
#digitalhealth#trends of 2019 -->#AI#telehealth#IoMT#VR#SeniorCare#valuebasedcare#patientfirst Ft.@Path_AI@buoyhealth@AmericanWell@aavia_io@AkiliLabs@kyruus@PatientPing@DevotedHealthhttps://masschallenge.org/article/how-massachusetts-companies-shaped-disruptive-digital-health-trends#.XfOGUaqiCZc.twitter …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PathAI proslijedio/la je Tweet
"... there was no call for the use of these tools from practicing clinicians. Few physicians ... received training in quantitative methods; therefore, they neither saw a need for probabilistic estimates, nor could they properly apply them ..."https://ja.ma/2qBC2Cs
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are so excited to welcome Michael Montalto to the PathAI family as Chief Scientific Officer! Mike worked closely with us during his role at BMS, bringing a ton of experience in biomarkers, imaging discovery, & IVDs—the perfect new addition to the team!https://www.pathai.com/news/pathai-montalto-chief-scientific-officer …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PathAI proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
PathAI proslijedio/la je Tweet
Improving the accuracy of
#NASH diagnosis and monitoring is crucial to better understanding the disease. We’re working with@Path_AI to advance methods for interpreting liver histology and characterizing disease progression.#LiverMtg19pic.twitter.com/qTuK9vrOiDHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
NASH is an incredibly impactful disease, and
@GileadSciences has been doing a ton of work toward understanding its mechanism and producing potential treatments. We're excited to play a core role in helping accelerate and amplify their research efforts: https://www.gilead.com/news-and-press/press-room/press-releases/2019/11/data-showing-potential-for-machine-learning-to-advance-understanding-of-nonalcoholic-steatohepatitis-nash-presented-at-the-liver-meeting-2019 …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
If you thought we only worked on cancer, we've got even more news for you this week. Today marks the opening of
#LiverMtg19 here in Boston, and we're sharing the results of two NASH-related research efforts with our partners at@GileadSciences:https://www.pathai.com/news/pathai-gilead-nash-aasld-liver-2019 …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PathAI proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
PathAI proslijedio/la je Tweet
Digital pathology startup
@Path_AI closes $75M Series B round with investments from BMS, Merck by@biotechvisigoth https://medcitynews.com/2019/11/digital-pathology-startup-pathai-closes-75m-series-b-round-with-investments-from-bms-merck/ …@bmsnews@Merck#pathology#VentureCapitalHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PathAI proslijedio/la je Tweet
To most folks, this is gobbledygook. But once you peel back the jargon, you can see that we (& our partners) are making inroads into some of the keys to what I think of as science's current-best-hope to cure cancer. Here's how I think about this, coming from the tech side… 1/https://twitter.com/Path_AI/status/1191714148159250434 …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
More big news this week: We're announcing research at
#SITC2019! Among the highlights: accurate tumor & immune cell PD-L1 quantification and similar patient response prediction across three phase 3 lung cancer trials of Opdivo (nivolumab), with@bmsnewshttps://www.pathai.com/news/pathai-bms-sitc-2019 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How often can you say that the two of the biggest names in pharmaceuticals agreed on the same thing? We are honored that
@Merck and@bmsnews have invested in PathAI and our mission:https://www.pathai.com/news/pathai-merck-ghif-bms-strategic-investment …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our very own VP of Regulatory & Clincal Affairs, Esther Abels, speaking at
#PathVisions19! Don't miss her article and the associated white paper she authored on the regulatory impacts on digital pathology: https://digitalpathologyassociation.org/blog/how-to-move-the-ai-regulatory-needle/ …https://twitter.com/dpatweet/status/1181659068085219328 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
That’s our very own
@kristinruben
https://twitter.com/VueVixens/status/1179770650031988736 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're so excited to meet so many fantastic women in tech at
#GHC19! Stop by booth 477 to find out more about us and ways we could work together: https://pathai.com/careers/ And make sure to RSVP to our happy hour! https://www.eventbrite.com/e/pathai-ghc-2019-tickets-70697876251 …pic.twitter.com/jbgSVgL3Mb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PathAI proslijedio/la je Tweet
Sitting at my desk here
@Path_AI, I'm surrounded on all sides by women – and I'm including the diagonals. Pretty amazing for a tech company, and unique so far in my career. Most of all, great progress from where we were just a couple years ago.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PathAI proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.